196 related articles for article (PubMed ID: 33711412)
1. Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial).
Robijns J; Lodewijckx J; Claes S; Van Bever L; Pannekoeke L; Censabella S; Bussé L; Colson D; Kaminski I; Broux V; Puts S; Vanmechelen S; Timmermans A; Noé L; Bulens P; Govers M; Maes A; Mebis J
Radiother Oncol; 2021 May; 158():268-275. PubMed ID: 33711412
[TBL] [Abstract][Full Text] [Related]
2. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
[TBL] [Abstract][Full Text] [Related]
3. Photobiomodulation therapy for the prevention of acute radiation dermatitis in breast cancer patients undergoing hypofractioned whole-breast irradiation (LABRA trial).
Robijns J; Lodewijckx J; Puts S; Vanmechelen S; Van Bever L; Claes S; Pannekoeke L; Timmermans A; Noé L; Govers M; Van de Werf E; Maes A; Bulens P; Mebis J
Lasers Surg Med; 2022 Mar; 54(3):374-383. PubMed ID: 34481420
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic NS-21 maintains the skin moisture but does not reduce the severity of radiation dermatitis in patients with head and neck cancer: a randomized control trial.
Chou HL; Shueng PW; Liao LJ; Hsu CX; Kuo DY; Lo WC; Hou PY; Wang LY; Chou SF; Hsieh CH
Radiat Oncol; 2019 May; 14(1):90. PubMed ID: 31146741
[TBL] [Abstract][Full Text] [Related]
5. Biophysical skin measurements to evaluate the effectiveness of photobiomodulation therapy in the prevention of acute radiation dermatitis in breast cancer patients.
Robijns J; Censabella S; Claes S; Pannekoeke L; Bussé L; Colson D; Kaminski I; Lodewijckx J; Bulens P; Maes A; Noé L; Brosens M; Timmermans A; Lambrichts I; Somers V; Mebis J
Support Care Cancer; 2019 Apr; 27(4):1245-1254. PubMed ID: 30270415
[TBL] [Abstract][Full Text] [Related]
6. Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)".
Baiocchi JMT; Fischer-Sgrott F; Baiocchi G
Radiother Oncol; 2021 Oct; 163():240-241. PubMed ID: 34274394
[No Abstract] [Full Text] [Related]
7. Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)" by Baiocchi et al.
Robijns J; Lodewijckx J; Claes S; Van Bever L; Pannekoeke L; Censabella S; Bussé L; Colson D; Kaminski I; Broux V; Puts S; Vanmechelen S; Timmermans A; Noé L; Bulens P; Govers M; Maes A; Mebis J
Radiother Oncol; 2021 Oct; 163():242-243. PubMed ID: 34274395
[No Abstract] [Full Text] [Related]
8. Response to the Letter to the editor by Donnelly et al. regarding the article "Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)".
Robijns J; Lodewijckx J; Claes S; Van Bever L; Pannekoeke L; Censabella S; Bussé L; Colson D; Kaminski I; Broux V; Puts S; Vanmechelen S; Timmermans A; Noé L; Bulens P; Govers M; Maes A; Mebis J
Radiother Oncol; 2021 Aug; 161():255-256. PubMed ID: 34119590
[No Abstract] [Full Text] [Related]
9. Letter to the editor regarding the article "Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)" by Robijns et al. Radiat Oncol. 2021.
Donnelly O; Goranova R; Nugent M
Radiother Oncol; 2021 Aug; 161():254. PubMed ID: 34144079
[No Abstract] [Full Text] [Related]
10. Prevention of acute radiodermatitis by photobiomodulation: A randomized, placebo-controlled trial in breast cancer patients (TRANSDERMIS trial).
Robijns J; Censabella S; Claes S; Pannekoeke L; Bussé L; Colson D; Kaminski I; Bulens P; Maes A; Noé L; Brosens M; Timmermans A; Lambrichts I; Somers V; Mebis J
Lasers Surg Med; 2018 Feb; ():. PubMed ID: 29427390
[TBL] [Abstract][Full Text] [Related]
11. Photobiomodulation therapy for the prevention of acute radiation dermatitis: a systematic review and meta-analysis.
Gobbo M; Rico V; Marta GN; Caini S; Ryan Wolf J; van den Hurk C; Beveridge M; Lam H; Bonomo P; Chow E; Behroozian T
Support Care Cancer; 2023 Mar; 31(4):227. PubMed ID: 36952036
[TBL] [Abstract][Full Text] [Related]
12. Preemptive treatment with Xonrid®, a medical device to reduce radiation induced dermatitis in head and neck cancer patients receiving curative treatment: a pilot study.
Iacovelli NA; Naimo S; Bonfantini F; Cavallo A; Bossi P; Fallai C; Pignoli E; Alfieri S; Bergamini C; Favales F; Orlandi E
Support Care Cancer; 2017 Jun; 25(6):1787-1795. PubMed ID: 28108819
[TBL] [Abstract][Full Text] [Related]
13. A Narrative Review on the Use of Photobiomodulation Therapy for the Prevention and Management of Acute Radiodermatitis: Proposed Mechanisms, Current Clinical Outcomes, and Preliminary Guidance for Clinical Studies.
Robijns J; Lodewijckx J; Bensadoun RJ; Mebis J
Photobiomodul Photomed Laser Surg; 2020 Jun; 38(6):332-339. PubMed ID: 32460613
[No Abstract] [Full Text] [Related]
14. Feasibility of photobiomodulation therapy for the prevention of radiodermatitis: a single-institution pilot study.
Park JH; Byun HJ; Lee JH; Kim H; Noh JM; Kim CR; Oh D
Lasers Med Sci; 2020 Jul; 35(5):1119-1127. PubMed ID: 31811498
[TBL] [Abstract][Full Text] [Related]
15. Effects of topical timolol for the prevention of radiation-induced dermatitis in breast cancer: a pilot triple-blind, placebo-controlled trial.
Nabi-Meybodi M; Sahebnasagh A; Hakimi Z; Shabani M; Shakeri AA; Saghafi F
BMC Cancer; 2022 Oct; 22(1):1079. PubMed ID: 36266613
[TBL] [Abstract][Full Text] [Related]
16. Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial.
Zenda S; Yamaguchi T; Yokota T; Miyaji T; Mashiko T; Tanaka M; Yonemura M; Takeno M; Okano T; Kawasaki T; Nakamori Y; Ishii S; Shimada S; Kanamaru M; Uchitomi Y
BMC Cancer; 2018 Sep; 18(1):873. PubMed ID: 30189840
[TBL] [Abstract][Full Text] [Related]
17. Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients.
Tao Y; Auperin A; Sire C; Martin M; Saliou MG; Bardet E; Sun XS; Chatellier T; Morand C; Cornely A; Angokai M; Di Rito A; Kichenin K; Blanchard P; D'Onofrio I; Bourhis J
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):590-595. PubMed ID: 29280453
[TBL] [Abstract][Full Text] [Related]
18. Photobiomodulation therapy for acute radiodermatitis.
Robijns J; Lodewijckx J; Mebis J
Curr Opin Oncol; 2019 Jul; 31(4):291-298. PubMed ID: 31170115
[TBL] [Abstract][Full Text] [Related]
19. New photobiomodulation device for prevention and cure of radiotherapy-induced oral mucositis and dermatitis: results of the prospective Safe PBM study.
Bensadoun RJ; Bollet MA; Liem X; Cao K; Magné N
Support Care Cancer; 2022 Feb; 30(2):1569-1577. PubMed ID: 34537889
[TBL] [Abstract][Full Text] [Related]
20. Phase 3 Randomized Trial of Topical Steroid Versus Placebo for Prevention of Radiation Dermatitis in Patients With Head and Neck Cancer Receiving Chemoradiation.
Yokota T; Zenda S; Ota I; Yamazaki T; Yamaguchi T; Ogawa T; Tachibana H; Toshiyasu T; Homma A; Miyaji T; Mashiko T; Hamauchi S; Tominaga K; Ishii S; Otani Y; Orito N; Uchitomi Y
Int J Radiat Oncol Biol Phys; 2021 Nov; 111(3):794-803. PubMed ID: 34102298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
